Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
Key facts
- Who runs it
- The University of Tennessee, Knoxville
- Where
- Knoxville, United StatesSee the site
- Trial code
- Status
- Withdrawn
- Started
- 8 Sept 2023
- Ended
- 8 May 2024
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Self-Administered Hypnosis
- Self-Administered White Noise Hypnosis
- Record updated
- 10 May 2024
- Why it stopped
- Unable to recruit participants
Who can take part
- Age
- 18 years to 99 years
- Sex
- Women only
- Healthy volunteers
- Cannot take part
Show the full registry criteria (12)Hide the full registry criteria
Who can take part
- 18 years of age or older Black female
- Diagnosed with Stage IV Breast Cancer with life expectancy of 6 months or more
- Ability to read and write English
- Ability to complete questionnaire(s) by themselves or with assistance
- Report cancer-related pain that they rate as ≥4 on a numeric pain rating scale of 0-10 with 0 being "no pain" and 10 being "the worst it can be" for the past month or more
- Ability to provide informed written consent
Who cannot take part
- Currently using hypnosis for any reason
- Diagnosis of major depressive disorder or acute anxiety disorder per the medical record or self-report in the past 2 years
- Serious psychological illness, specifically psychoses, schizophrenia, or borderline personality disorder per the medical record or self-report
- Currently enrolled in hospice
- Non-English speaking
- Unable to complete questionnaires or follow directions independently
Where in United States
- University of Tennessee - KnoxvilleKnoxville, United States
About the trial
What the trial wants to find out
The purpose of this study is to compare two hypnotic interventions for Black women with advanced cancer pain in preparation for a well-powered phase III study. The investigators plan to enroll 30 adult Black women with advanced cancer pain in a 2-arm pilot randomized controlled trial (RCT).
Read full original descriptionShow less
The primary aim will be to evaluate the feasibility of conducting the 2-arm clinical trial. It is hypothesized that at least 75% of participants in both study arms will complete study requirements. The secondary aims will be to evaluate the participant's experience with the intervention and to determine the effect size of the intervention on pain severity.
The 2 groups in the trial
- Self-Administered HypnosisTreatment being tested
Self-administered hypnosis will be practiced daily, at home for 6 weeks. Hypnosis sessions are expected to last \~20 minutes. Practices using the recordings will be documented on the Hypnosis Practice Log.
- Self Administered White Noise HypnosisExisting treatment, for comparison
Self-administered white noise hypnosis will be practiced daily using a white noise recording. Participants will practice hypnosis at home after completing the virtual consent/baseline visit and the virtual education visit.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 10 May 2024